Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of a ppar-delta agonist for reducing loss of muscle strength, muscle mass, or type I muscle fibers in an immobilized limb

Use of a ppar-delta agonist for reducing loss of muscle strength, muscle mass, or type I muscle fibers in an immobilized limb

US Patent 9968613 · Granted May 15, 2018

Estimated economic value: $635,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Therapeutic uses of glucokinase activators in combination with insulin or insuli2024
Therapeutic uses of glucokinase activators in combination with insulin or insuli2023
Use of a PPAR-δ agonist for reducing loss of muscle strength, muscle mass, or ty2021
Use of a PPAR-δ agonist for reducing loss of muscle strength, muscle mass, or ty2021
Glucokinase activator compositions for the treatment of diabetes2021
Therapeutic uses of glucokinase activators in combination with insulin or insuli2021
Compositions and methods of using modified release solabegron for lower urinary 2020
Pharmaceutical compositions and the treatment of overactive bladder2020
Glucokinase activator compositions for the treatment of diabetes2020
Use of a PPAR-δ agonist for reducing loss of muscle strength, muscle mass, or ty2019
Use of a PPAR-δ agonist for reducing loss of muscle strength, muscle mass, or ty2019
Compositions comprising metformin and a glucokinase activator2019